Want to see AGL full AI Analyst Report?
AGL Stock Chart & Stats
$30.05
$0.02(1.16%)
At close: 4:00 PM EST
$30.05
$0.02(1.16%)
Day’s Range― - ―
52-Week Range$7.48 - $133.04
Previous CloseN/A
Volume1.09M
Average Volume (3M)310.54K
Market Cap
$2.04B
Enterprise Value-$137.79
Total Cash (Recent Filing)$231.41M
Total Debt (Recent Filing)$33.40M
Price to Earnings (P/E)―
Beta2.44
Next Earnings
Aug 05, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.70
Shares Outstanding16,683,786
10 Day Avg. Volume314,156
30 Day Avg. Volume310,543
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.25
Price to Sales (P/S)0.05
P/FCF Ratio-2.40
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$62.46Price Target Upside107.86% Upside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)-3.09
Revenue Forecast (FY)$5.72B
Bulls Say, Bears Say
Bulls Say
Platform & Clinical ScaleAgilon's ability to deploy standardized clinical pathways at scale demonstrates durable operational leverage: reducing avoidable inpatient care and integrating pharmacy/therapy increases care quality while lowering downstream costs. This strengthens long-term value-based economics and supports stickier physician partnerships.
Risk-adjustment & Data CoverageBroader member-level data and better risk-score visibility materially improve revenue predictability under capitation and risk contracts. A sustained ~1.5% risk-score uplift reduces adverse selection noise, enhances reimbursement accuracy, and supports more reliable medical-margin planning over multiple quarters.
Modest Leverage / Balance Sheet FlexibilityLow debt levels provide structural financial flexibility while operations stabilize, reducing near-term solvency risk and preserving capacity to fund clinical investments or absorb timing mismatches in capitation payments. This limits refinancing pressure during the operational turnaround.
Bears Say
Persistent Losses And Cash BurnSustained negative margins and consistent cash outflows indicate the core business is not yet self-funding. Continued losses erode equity, constrain reinvestment capacity, and heighten dependence on external capital or asset sales, making long-term strategy execution and scale-up riskier if trends don't reverse.
Declining Medicare Advantage MembershipA sizable drop in MA membership undermines the capitated revenue base and scale-dependent cost advantages. Lower enrollment reduces spread opportunities on fixed platform costs, pressures revenue growth and medical-margin leverage, and slows the pathway to sustained profitability over multiple quarters.
Part D Reserving And Reimbursement UncertaintyMaterial uncertainty in Part D reconciliation creates recurring reserve risk that directly affects reported premiums and margins. Combined with limited visibility into CMS risk-model changes, this regulatory and timing volatility can persistently disrupt revenue recognition, reserve levels, and margin sustainability.
Agilon Health News
AGL FAQ
What was Agilon Health Inc’s price range in the past 12 months?
Agilon Health Inc lowest stock price was $7.48 and its highest was $133.04 in the past 12 months.
What is Agilon Health Inc’s market cap?
Agilon Health Inc’s market cap is $2.04B.
When is Agilon Health Inc’s upcoming earnings report date?
Agilon Health Inc’s upcoming earnings report date is Aug 05, 2026 which is in 14 days.
How were Agilon Health Inc’s earnings last quarter?
Agilon Health Inc released its earnings results on May 06, 2026. The company reported $2.94 earnings per share for the quarter, beating the consensus estimate of $1.041 by $1.899.
Is Agilon Health Inc overvalued?
According to Wall Street analysts Agilon Health Inc’s price is currently Undervalued.
Does Agilon Health Inc pay dividends?
Agilon Health Inc pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health Inc dividends here
What is Agilon Health Inc’s EPS estimate?
Agilon Health Inc’s EPS estimate is 0.11.
How many shares outstanding does Agilon Health Inc have?
Agilon Health Inc has 16,683,786 shares outstanding.
What happened to Agilon Health Inc’s price movement after its last earnings report?
Agilon Health Inc reported an EPS of $2.94 in its last earnings report, beating expectations of $1.041. Following the earnings report the stock price went up 117.81%.
Which hedge fund is a major shareholder of Agilon Health Inc?
Currently, no hedge funds are holding shares in AGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilon Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$62.46 (107.86% Upside)
$62.46 (107.86% Upside)
Blogger Sentiment
Bullish
AGL Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 10.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.8%
Last 30 Days ▲ 23.5%
Last 30 Days ▲ 23.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
135.10%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-22.14%
Trailing 12-Months
Company Description
Agilon Health Inc
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
AGL Stock 12 Month Forecast
Average Price Target
$62.46
▲(107.86% Upside)
Technical Analysis
AMN Healthcare Services
―
Cross Country Healthcare
―
InnovAge Holding
―
P3 Health Partners
―
biote
―
Ownership Overview
5.67% Insiders
16.61% Mutual Funds
0.26% Other Institutional Investors
67.37% Public Companies and
Individual Investors